|
|
|
|
| |
|
|
| |
Paper |
Graefes Arch Clin Exp Ophthalmol., April 2010
Rosentreter A, Mellein AC, Konen WW, Dietlein TS. (2010): Capsule excision and Ologen implantation for revision after glaucoma drainage device surgery. Graefes Arch Clin Exp Ophthalmol., 2010 Apr 20. [Epub ahead of print]
 |
Glaucoma Today, February 2010
Steven R. Sarkisian (2010): A REPLACEMENT FOR ANTIMETABOLITES? Ologen is a new product that modulates wound healing in glaucoma surgery. Glaucoma Today.,8:22-24
|
Updated Publication List, August 2010
Academic journal publications & Presented abstracts/ posters in Ophthalmology congress meetings
 |
Acta Ophthalmologica, February 2010
Papaconstantinou, D., Georgalas, I., Karmiris, E., Diagourtas, A., Koutsandrea, C.,
Ladas, I., Apostolopoulos, M., and Georgopoulos, G. (2010): Trabeculectomy
with ologen versus trabeculectomy for the treatment of glaucoma: a pilot study.
Acta Ophthalmol., 88: 80‐85. NOTE: OculusGen™ Collagen Matrix has been renamed into ologen™ Collagen Matrix in
July 2007. The implants used in this study are Oculusgen™ Collagen Matrix. The
material constituents and the physical properties of OculusGen™ Collagen Matrix
has been improved and upgraded for better performance and efficacy. This becomes
ologen™ Collagen Matrix. Furthermore, when ologen™ Collagen Matrix is applied in
trabeculectomy, loose suture on the sclera flap is strongly recommended.
|
Doctor Presentation |
ologen collagen matrix in strabismus by Dr. Emilio C. Campos, Italy, December 2009
33rd meeting of the European strabismological Association.
4-7 October 2009. Belgrade, Serbia. Ophthalmic Clinic University of Bologna, Italy
|
Paper |
Expert Rev. Ophthalmol., October 2009
Rao, K., Ahmed, I., Blake, D.A., and Ayyala, R.S. (2009): New devices in glaucoma
surgery. Expert Rev. Ophthalmol., 4: 491‐504. NOTE: In this review, all the references cited under iGEN™ collagen implant were originally referred to ologen™ Collagen Matrix. The authors of
this review and the publisher of the journal have been asked to issue an erratum in
order not to misleading the readers.
|
European Journal of Ophthalmology, March 2009
Aptel, F., Dumas, S., and Denis, P. (2009): Ultrasound biomicroscopy and optical
coherence tomography imaging of filtering blebs after deep sclerectomy with
new collagen implant. Eur. J. Ophthalmol., 19: 223‐230
|
Graefes Arch Clin Exp Ophthalmol., December 2008
Dietlein, T.S., Jordan, J., Lueke, C., and Krieglstein, G.K. (2008): Modern concepts
in antiglaucomatous implant surgery. Graefes Arch. Clin. Exp. Ophthalmol., 246: 1653‐1664.
|
|
Expert Rev. Ophthalmol., December 2008
Zelefsky, J.R., Hsu, W.C., and Ritch, R. (2008): Biodegradable collagen matrix
implant for trabeculectomy. Expert Rev. Ophthalmol., 3: 613‐617. Note : OculusGen™ brand has been changed to ologen™ since 2008 and marketed by Aeon Astron Europe B.V.
|
Animal Study |
Invest Ophthalmol Vis Sci., August 2000
Hsu, W.C., Spilker, M.H., Yannas, I.V., Rubin, P.A. (2000): Inhibition of Conjunctival Scarring and Contraction by a Porous Collagen-Glycosaminoglycan Implant. Invest Ophthalmol Vis Sci., 41: 2404-2411.
|
|
|
|
|
|
|
|
|
|
|
